Medscape Onsite: Bladder Cancer Updates From the Annual GU Meeting

Monday, February 5, 2024

12:30 pm – 1:00 pm  ET

Virtual
CME

OVERVIEW

Data from the latest trials in bladder cancer will be reported at the 2024 ASCO Genitourinary Cancers Symposium. Join Drs Matthew Galsky and Neal Shore as they discuss the findings and examine their implications for practice.

FACULTY

TARGET AUDIENCE

This activity is intended for oncologists, urologists, and other clinicians who care for patients with cancer.

GOAL STATEMENT

The goal of this activity is for learners to be better able to know the latest clinical data presented at an annual American genitourinary (GU) meeting regarding the management of bladder cancer and to provide recommendations for integrating the data into clinical practice.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Key clinical trial data for the treatment reported at a major oncology medical meeting [item]Utility of emerging data from a major oncology medical meeting into the treatment paradigms for patients [/list]Demonstrate greater confidence in their ability to: [list][item]Stay abreast of evolving therapeutic areas of interest from a major oncology medical meeting [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 0.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.